跳至主要内容
临床试验/NCT04181606
NCT04181606已完成早期 1 期

Age Comparisons of Exercising Muscle O2 Supply in Healthy Adults: Effects of Esmolol Infusion

David N. Proctor, PhD1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年2月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Tissue Saturation Index (TSI) - Active Leg Muscle

研究概览

简要总结

This study will test the central hypothesis that postmenopausal women will demonstrate increased oxygen extraction in active leg muscle during leg cycling exercise while receiving an infusion of Esmolol, a fast-acting β1 selective antagonist, when compared to premenopausal women

详细描述

This study will test the central hypothesis that postmenopausal women will demonstrate increased oxygen extraction in active leg muscle during leg cycling exercise while receiving an infusion of Esmolol, a fast-acting β1 selective antagonist, when compared to premenopausal women. β1 selective antagonists (or "β1 blockers") are used to lower heart rate and improve O2 supply-to-demand balance in patients with coronary artery disease. By using esmolol to attenuate the central sympathetic response to exercise (increased heart rate and cardiac output) we can examine peripheral mechanisms of O2 delivery. The current project will evaluate how older postmenopausal women adjust active muscle O2 supply to an acute reduction in systemic O2 delivery during large muscle dynamic exercise when compared to younger premenopausal women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

The participants, investigators, and data analysts (outcomes assessors) will be blinded to the treatment (drug) order. The care providers (research nurse and physician) will be aware of the treatment order for safety reasons i.e., they will be assessing heart rate, blood pressure and symptoms before, during, and after the infusion.

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Esmolol Infusion

Active Comparator

Drug: Esmolol Hydrochloride Dosage form: Intravenous Infusion Dosage/Frequency: 0.5 mg/(kg Fat Free Mass·min) for 3 min followed by a maintenance infusion of 0.25 mg/(kg Fat Free Mass·min) for remainder of trial, up to a maximum of 1 hour.

干预措施: Esmolol infusion (Drug)

Esmolol Infusion

Active Comparator

Drug: Esmolol Hydrochloride Dosage form: Intravenous Infusion Dosage/Frequency: 0.5 mg/(kg Fat Free Mass·min) for 3 min followed by a maintenance infusion of 0.25 mg/(kg Fat Free Mass·min) for remainder of trial, up to a maximum of 1 hour.

干预措施: Pre exercise baseline (Other)

Esmolol Infusion

Active Comparator

Drug: Esmolol Hydrochloride Dosage form: Intravenous Infusion Dosage/Frequency: 0.5 mg/(kg Fat Free Mass·min) for 3 min followed by a maintenance infusion of 0.25 mg/(kg Fat Free Mass·min) for remainder of trial, up to a maximum of 1 hour.

干预措施: Isometric handgrip exercise (Other)

Esmolol Infusion

Active Comparator

Drug: Esmolol Hydrochloride Dosage form: Intravenous Infusion Dosage/Frequency: 0.5 mg/(kg Fat Free Mass·min) for 3 min followed by a maintenance infusion of 0.25 mg/(kg Fat Free Mass·min) for remainder of trial, up to a maximum of 1 hour.

干预措施: Semi-recumbent cycling (Other)

Saline Infusion

Placebo Comparator

Saline infusion volume/rate matched to the calculated dose of esmolol.

干预措施: Saline infusion (Drug)

Saline Infusion

Placebo Comparator

Saline infusion volume/rate matched to the calculated dose of esmolol.

干预措施: Pre exercise baseline (Other)

Saline Infusion

Placebo Comparator

Saline infusion volume/rate matched to the calculated dose of esmolol.

干预措施: Isometric handgrip exercise (Other)

Saline Infusion

Placebo Comparator

Saline infusion volume/rate matched to the calculated dose of esmolol.

干预措施: Semi-recumbent cycling (Other)

结局指标

主要结局

Tissue Saturation Index (TSI) - Active Leg Muscle

时间窗: Last 60 seconds of Rest, Moderate exercise, and Heavy Exercise.

The primary outcome variable is the change in skeletal muscle oxygenation (∆TSI%) in the active leg muscle from baseline during recumbent cycling using near-infrared spectroscopy. TSI% represent the percentage of oxygenated hemoglobin relative to total hemoglobin in the tissue beneath the NIRS probe. Lower values represent a greater reduction in tissue oxygenation from baseline (greater oxygen extraction and/or reduced oxygen delivery). TSI% = oxy\[heme\] / total\[heme\] x 100

次要结局

  • Tissue Saturation Index - Inactive Forearm Muscle(Last 60 seconds of Rest, Moderate exercise, and Heavy Exercise.)
  • Systolic Blood Pressure(At rest and 3 minutes into moderate exercise and heavy exercise.)
  • Heart Rate(Last 60 seconds of Rest, Moderate exercise, and Heavy Exercise.)
  • Cardiac Output(Last 60 seconds of Rest, Moderate exercise, and Heavy Exercise.)
  • Diastolic Blood Pressure(At rest and 3 minutes into moderate exercise and heavy exercise.)
  • Mean Arterial Pressure(At rest and 3 minutes into moderate exercise and heavy exercise.)
  • Stroke Volume(Last 60 seconds of Rest, Moderate exercise, and Heavy Exercise.)
  • Systemic Vascular Conductance(Last 60 seconds of Rest, Moderate exercise, and Heavy Exercise.)
  • ∆HHb - Inactive Forearm(Last 60 seconds of Moderate and Heavy Exercise)

研究者

发起方
David N. Proctor, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

David N. Proctor, PhD

Professor of Kinesiology, Physiology, and Medicine

Penn State University

研究点 (1)

Loading locations...

相似试验